News
In this study, adults with type 1 diabetes initiated a regimen of TI plus insulin degludec after completing the usual-care control group of a randomized trial. Roy Beck, MD, Ph.D., from the JAEB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback